Summary
Ninety-three patients with gram-negative bacillary meningitis (GNBM) were identified at Kaohsiung Chang Gung Memorial Hospital, over a period of 12 years. Among them, eight showed resistance to third-generation cephalosporins, accounting for 9% of the total GNBM cases and 29% of the postneurosurgical GNBM cases. The resistant pathogens includedAcinetobacter baumannii, Klebsiella pneumoniae, Citrobacter freundii andMorganella morganii. These eight patients, six males and two females aged 18–61 years, all had nosocomially acquired meningitis associated with head trauma and/or postneurosurgical states. Six patients received imipenem/cilastatin treatment; five survived and one died. The other two expired because they did not receive appropriate antibiotic treatment. Although third-generation cephalosporin-resistant GNBM is rare, its incidence has been increasing over the past 5 years. In patients with nosocomially-acquired postneurosurgical GNBM, the presence of third-generation cephalosporin resistnace should therefore be highly suspected. The appropriate choice of antibiotic is essential for their survival.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berk, S. L., McCabe, W. R.: Meningitis caused by gram-negative bacilli. Ann. Intern. Med. 93 (1980) 253–260.
Mancebo, J., Domingo, P., Blanch, L., Coll, P., Net, A., Nolla, J.: Post-neurosurgical and spontaneous gram-negative bacillary meningitis in adults. Scand. J. Infect. 18 (1986) 533–538.
Quagliarello, V. J., Scheld, W. M.: Treatment of bacterial meningitis. N. Engl. J. Med. 336 (1997) 708–716.
Smith, C. E., Tillman, B. S., Howell, A. W., Longfield, R. D., Jorgensen, J. H.: Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due toKlebsiella pneumoniae producing an extended-spectrum β-lactamase. Antimicrob. Agents Chemother. 34 (19900 1290–1293.
Preston, S. L., Briceland, L. L.: Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistantEscherichia coli. Ann. Pharmacother. 27 (1993) 870–873.
Sirot, D. L., Goldstein, F. W., Soussy C. J., Courtieu, A. L., Husson, M. O., Lemozy, J.: Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob. Agents Chemother. 36 (1992) 1677–1681.
Jacoby, G. A., Carreras, I.: Activities of β-lactam antibiotics againstEscherichia coli strains producing extended spectrum β-lactamase. Antimicrob. Agents Chemother. 34 (1990) 858–862.
Aubert, G., Jacquemond, G., Pozzetto, B., Duthel, R., Baylot, D., Brunon, J.: Pharmacokinetic evidence of imipenem efficacy in the treatment ofKlebsiella pneumoniae nosocomial meningitis. J. Antimicrob. Chemother. 28 (1991) 316–317.
Baltas, I., Tsoulfa S., Sakellariou, P., Vogas, V., Fylaktakis, M., Kondodimou, A.: Posttraumatic meningitis: bacteriology, hydrocephalus, and outcome. Neurosurgery 35 (1994) 422–427.
Mombelli, G., Klastersky, J., Coppens, L., Daneau, D., Nubourgh, Y.: Gram-negative bacillary meningitis in enurosurgical patients. J. Neurosurg. 59 (1983) 634–641.
Berk, S. L., McCabe, W. R.: Meningitis caused byAcinetobacter calcoaceticus var anitratus, a specific hazard in neurosurgical patients. Arch. Neurol. 38 (1981) 95–98.
Sanders, W. E. Jr., Sanders, C. C.: Inducible β-lactamase: clinical and epidemiologic implications for use of newer cephalosporins. Rev. Infect. Dis. 10 (1988) 830–838.
Gold, H. S., Moellering, R. C. Jr.: Antimicrobial-drug resistance. N. Engl. J. Med. 335 (1996) 1445–1452.
Jacobs, R. F.: Imipenem-cilastatin: the first thienamycin antibiotic. Pediatr. Infect. Dis. 5 (1986) 444–448.
Wong, V. K., Wright, H. T., Ross, L. A., Mason, W. H., Inderlied, C. B., Kim, K. S.: Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr. Infect. Dis. J. 10 (1991) 122–125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lu, C.H., Chang, W.N. & Chuang, Y.C. Resistance to third-generation cephalosporins in adult gram-negative bacillary meningitis. Infection 27, 208–211 (1999). https://doi.org/10.1007/BF02561530
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02561530